Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

February 28, 2021

Conditions
Epidermoid CarcinomaAnus
Interventions
DRUG

radiochemotherapy

Radiotherapy : PTV1 45 Gy 5 weeks PTV2 20 Gy 2 weeks Chemotherapy : 5Fu (400 to 1000 mg/m²) mitomycin : 10 mg/m²

DRUG

Panitumumab

3 or 6 mg/kg (according to dose level)

Trial Locations (15)

Unknown

Pessac - Hôpital Haut Lévêque, Bordeaux

CH - Hopitaux civils de Colmar, Colmar

Centre d'oncologie et de radiothérapie du Parc, Dijon

Centre Oscar Lambret, Lille

CH - CHBS - Hôpital du Scorff, Lorient

Centre Léon Bérard, Lyon

Institut Régional du Cancer Montpellier, Montpellier

Clinique Privée - Plein Ciel, Mougins

Institut Curie, Paris

Cario - HPCA - Hôpital privé des Côtes D'Armor, Plérin

CH - Annecy Genevois, Pringy

Centre Eugène Marquis, Rennes

Institut Curie, Saint-Cloud

CHU, Saint-Priest-en-Jarez

CAC - Paul Strauss, Strasbourg

All Listed Sponsors
lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT01581840 - Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus | Biotech Hunter | Biotech Hunter